Xtant Medical Statistics
Share Statistics
Xtant Medical has 139.01M shares outstanding. The number of shares has increased by 6.84% in one year.
| Shares Outstanding | 139.01M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.21% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 51.55M |
| Failed to Deliver (FTD) Shares | 123.94K |
| FTD / Avg. Volume | 96.14% |
Short Selling Information
The latest short interest is 197.47K, so 0.14% of the outstanding shares have been sold short.
| Short Interest | 197.47K |
| Short % of Shares Out | 0.14% |
| Short % of Float | 0.38% |
| Short Ratio (days to cover) | 6.92 |
Valuation Ratios
The PE ratio is 203.9 and the forward PE ratio is -16.48. Xtant Medical 's PEG ratio is 1.02.
| PE Ratio | 203.9 |
| Forward PE | -16.48 |
| PS Ratio | 1.47 |
| Forward PS | 0.4 |
| PB Ratio | 2.62 |
| P/FCF Ratio | -12.27 |
| PEG Ratio | 1.02 |
Enterprise Valuation
Xtant Medical Inc. has an Enterprise Value (EV) of 152.21M.
| EV / Earnings | 230.62 |
| EV / Sales | 1.67 |
| EV / EBITDA | 29.99 |
| EV / EBIT | -14.98 |
| EV / FCF | -13.87 |
Financial Position
The company has a current ratio of 2.82, with a Debt / Equity ratio of 0.42.
| Current Ratio | 2.82 |
| Quick Ratio | 1.22 |
| Debt / Equity | 0.42 |
| Total Debt / Capitalization | 29.79 |
| Cash Flow / Debt | -0.44 |
| Interest Coverage | -3.46 |
Financial Efficiency
Return on equity (ROE) is 0.01% and return on capital (ROIC) is 8.63%.
| Return on Equity (ROE) | 0.01% |
| Return on Assets (ROA) | 0.01% |
| Return on Capital (ROIC) | 8.63% |
| Revenue Per Employee | 441.08K |
| Profits Per Employee | 3.19K |
| Employee Count | 207 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 0.97 |
Taxes
| Income Tax | -1.70M |
| Effective Tax Rate | 1.64 |
Stock Price Statistics
The stock price has increased by -57.98% in the last 52 weeks. The beta is 0.39, so Xtant Medical 's price volatility has been higher than the market average.
| Beta | 0.39 |
| 52-Week Price Change | -57.98% |
| 50-Day Moving Average | 0.45 |
| 200-Day Moving Average | 0.66 |
| Relative Strength Index (RSI) | 72.08 |
| Average Volume (20 Days) | 128.93K |
Income Statement
In the last 12 months, Xtant Medical had revenue of 91.30M and earned 660.00K in profits. Earnings per share was 0.01.
| Revenue | 91.30M |
| Gross Profit | 55.47M |
| Operating Income | -10.16M |
| Net Income | 660.00K |
| EBITDA | 5.07M |
| EBIT | -10.16M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 5.71M in cash and 23.56M in debt, giving a net cash position of -17.84M.
| Cash & Cash Equivalents | 5.71M |
| Total Debt | 23.56M |
| Net Cash | -17.84M |
| Retained Earnings | -243.01M |
| Total Assets | 98.88M |
| Working Capital | 37.74M |
Cash Flow
In the last 12 months, operating cash flow was -9.52M and capital expenditures -1.46M, giving a free cash flow of -10.97M.
| Operating Cash Flow | -9.52M |
| Capital Expenditures | -1.46M |
| Free Cash Flow | -10.97M |
| FCF Per Share | -0.09 |
Margins
Gross margin is 6.08K%, with operating and profit margins of -1.11K% and 72%.
| Gross Margin | 6.08K% |
| Operating Margin | -1.11K% |
| Pretax Margin | -114% |
| Profit Margin | 72% |
| EBITDA Margin | 5.56% |
| EBIT Margin | -11.13% |
| FCF Margin | -12.02% |
Dividends & Yields
XTNT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 2% |
| FCF Yield | -15.8% |
Analyst Forecast
The average price target for XTNT is $3, which is 500% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3 |
| Price Target Difference | 500% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on Feb 14, 2018. It was a backward split with a ratio of 1:12.
| Last Split Date | Feb 14, 2018 |
| Split Type | backward |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | -1.84 |
| Piotroski F-Score | 2 |